Merck & Co., Inc.MRKNYSE
Loading
Net Income PerformanceStrong
Percentile Rank100
3Y CAGR+7.9%
5Y CAGR+20.9%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+7.9%/yr
vs +23.6%/yr prior
5Y CAGR
+20.9%/yr
Recent deceleration
Acceleration
-15.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $18.25B | +6.6% |
| 2024 | $17.12B | +4589.6% |
| 2023 | $365.00M | -97.5% |
| 2022 | $14.52B | +11.3% |
| 2021 | $13.05B | +84.6% |
| 2020 | $7.07B | -28.2% |
| 2019 | $9.84B | +58.2% |
| 2018 | $6.22B | +159.8% |
| 2017 | $2.39B | -38.9% |
| 2016 | $3.92B | - |